conducted a population-based, cross sectional survey of NYC adults modeled after the National Health and Nutrition Examination Survey (HANES). The methodology for NYC HANES has been described in detail elsewhere (1). In brief, the survey population included a representative sample of non-institutionalized adults, ages 20 and older, recruited through letters and field visits, followed up by interviews, physical examination and biologic specimen collection for consenting participants. A 3-stage cluster sampling plan was used to recruit participants between June and December 2004. The stages of sample selection were as follows: 1) selection of census blocks or groups of blocks; 2) random selection of households within selected segments; and 3) random selection of study participants within households. The survey included a face-to-face computer-assisted personal interview, private audio computer-assisted self-interview, physical examination, and laboratory testing (sera and urine). The overall response rate was 55%.
collected at the time of interview included age, race/ethnicity, country of birth, and gender.
Occupational and influenza histories were not collected.
Specimen Sampling
From the specimen repository we randomly selected serum samples from those persons born in 1981 or earlier (persons age 23 or older at the time of the NYC HANES collection) to include in this study. This would allow us to better understand prior exposure to H1N1 (presumably conferring immunity), which might explain the age-related pattern of illness seen during the 2009 H1N1 pandemic in New York City and elsewhere. Other objectives were to understand the patterns of measurable neutralizing antibody titers to the 1918 H1N1, 1957 H2N2, and 1968 H3N2 pandemic influenza viruses.
The total sample size of NYC HANES was 1,999. Of these, 1,811 completed the serosurvey component. Serum specimens were collected from most consenting participants and are stored at the NYCDOHMH's Public Health Laboratory at -70 C. From these, a subsample of 400 was selected for testing. The data were weighted to adjust for the complex sampling, design nonresponse, and post-stratification. The weights were further adjusted to address componentand item-nonresponse
The subsample was drawn in such a way as to address two distinct purposes of the study.
The first was to establish a cutoff birth date, before which individuals may show an increased likelihood of cross-reactivity to the 2009 H1N1 virus . The second was to estimate the level of cross-reactive antibodies for those born before the cutoff. The first purpose favors selecting more samples around the potential cutoff while the second favors selecting sample from respondents born before the cutoff. After establishing a potential range for the cutoff value, the sample was drawn with increasing probability in the range, very low probability below the range, and moderate probability above the range. Component weights were adjusted by their inverse probability of selection into the subsample and then scaled to the population total.
Laboratory Testing
Human Sera Treatment:
Human sera was treated with trypsin periodate, according to established procedures, to remove nonspecific inhibitors of hemagglutination (2) . Locally weighting smoothing scatterplots (LOESS curves) (5) were used to estimate the prevalence of antibodies by year of birth. To appropriately account for the complex survey design of NYC HANES, logistic regression models were fit using Sudaan version 10.0 (6).
Nonlinear models were used to explicitly estimate the cutoff year for increased probability of immunity, using a segmented regression model that includes cutoff year as a parameter (7).
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